⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

Mylan Pharmaceuticals Inc: Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., Manufactured for: Mylan Phar

DrugsSource: FDA (drug) · Date: 2026-08-26

Read the official notice at FDA (drug) →

Share on XFacebookRedditEmail

Get alerts for Mylan Pharmaceuticals

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.

Company / brand
Mylan Pharmaceuticals Inc
Product
Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 266505, NDC 0378-6333-80.
Reason / hazard
Failed Dissolution Specifications
Classification
Class II
Status
Ongoing
Distribution / sold at
US Nationwide.
Recall initiated
2026-07-24
Code info
Lot# 3227809; Expiry:10/2026; NDC #: 0378-6333-80
Voluntary mandated
Voluntary: Firm initiated
City
Morgantown
State
WV
Country
United States
Event id
99483
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.